LeonaBio, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | – | +90.8% | +76.4% | +14.7% | +0.1% | +0.2% | |
| – | +29.1% | +150.2% | +630.3% | +129.4% | +0.2% | +4.0% | -44.8% | |
| – | +176.7% | -1,050.6% | – | +98.8% | -45.3% | -283.6% | – | |
| – | – | – | -32.2% | -27.5% | -73.4% | -89.1% | -100.0% | |
| – | -25.0% | -14,048.7% | -98.1% | – | +64.9% | -42.3% | -129.0% | |
| – | – | – | – | – | – | – | – | |
| – | -35.4% | +30,846.1% | -66.8% | -99.3% | -24.6% | -60.6% | +42,405.7% | |
| – | – | – | -14.8% | -128.4% | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.